by lumina | Nov 7, 2025 | Artificial Intelligence, Executive Insights, Lumina RCL, LuminaRCL, Machine Learning, PrismRCL
The upcoming AI wave isn’t about mastering any single data type and building on that. Rather, it will be about bringing them together. Enterprises these days are increasingly seeking a cross-modal AI framework that can unify structured data from different...
by lumina | Oct 21, 2025 | Artificial Intelligence, Executive Insights, Lumina RCL, Lumina Updates, LuminaRCL, Machine Learning, PrismRCL, RCL
Cyber threats are evolving – faster, smarter, and more difficult to detect.Traditional rule-based systems often fall behind, reacting only after an attack is underway. For this reason, cybersecurity teams are turning to AI, not just for detection, but for...
by lumina | Oct 10, 2025 | Artificial Intelligence, Lumina RCL
Smart factories are emerging as the foundation of contemporary manufacturing and retail. Although factories have long embraced automation, real-time thinking, learning, and adapting systems are necessary for the next big step. That’s why AI in demand forecasting is...
by lumina | Sep 29, 2025 | Artificial Intelligence, Lumina RCL, Lumina Updates, LuminaRCL, Machine Learning
Retail is a fast-paced industry. Your top-selling winter coats are selling out in a flash, and then you have too much inventory, which is reducing your earnings due to unforeseen warm weather. Accurate forecasting is not only useful but also necessary for businesses...
by lumina | Sep 12, 2025 | Artificial Intelligence, Lumina RCL, LuminaRCL, Machine Learning, PrismRCL, RCL
AI-driven fraud is evolving fast, and it isn’t just a financial threat. From suspicious insurance claims to abnormal banking transactions, fraud may cost billions, disrupt corporate operations, and erode consumer confidence. The methods used to detect fraudulent...
by lumina | Sep 5, 2025 | Artificial Intelligence, Lumina RCL, LuminaRCL, Machine Learning
Healthcare innovation continues to streamline diagnostic workflows. In medicine, if AI is being used, nothing reaches patients without rigorous AI validation, whether it’s a new drug or a diagnostic tool. The questions is no longer if AI will shape clinical care, but...
